Markets:

Overview

News

Currencies

International

Treasuries

Legend Biotech Corporation - American Depositary Shares (NQ:LEGN)

29.48 +0.97 (+3.40%)

Streaming Delayed Price Updated: 11:16 AM EDT, May 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Legend Biotech Corporation - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >

Is Yum China a Buy After Investment Firm Matthews Purchased Shares Worth $12.57 Million? ↗

May 05, 2026

Yum China operates thousands of quick-service and casual dining restaurants across China under well-known international brands.

Via The Motley Fool

Topics Regulatory Compliance

Matthews Just Slashed Its Futu Position -- Here’s Why That Matters ↗

May 04, 2026

Futu Holdings delivers digital brokerage and wealth management services to retail and institutional clients across Asia and global markets.

Via The Motley Fool

Why Legend Biotech Stock Crushed the Market on Monday ↗

April 20, 2026

Two analysts weighed in positively about the company's future.

Via The Motley Fool

Legend Biotech Corp. (NASDAQ:LEGN) Reports Mixed Q4 2025 Results, Beats on EPS ↗

March 10, 2026

Via Chartmill

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

What to Expect from Legend Biotech's Earnings ↗

November 11, 2025

Via Benzinga

Legend Biotech (LEGN) Q4 2025 Earnings Transcript ↗

April 01, 2026

Legend Biotech (LEGN) Q4 2025 Earnings Transcript

Via The Motley Fool

Legend Biotech (LEGN) Q2 2025 Earnings Transcript ↗

April 01, 2026

Legend Biotech (LEGN) Q2 2025 Earnings Transcript

Via The Motley Fool

Legend Biotech (LEGN) Q4 2024 Earnings Transcript ↗

April 01, 2026

Legend Biotech (LEGN) Q4 2024 Earnings Transcript

Via The Motley Fool

Topics Earnings Economy World Trade

How Do Investors Really Feel About Legend Biotech? ↗

September 22, 2025

Via Benzinga

Legend Biotech (LEGN) Q1 2025 Earnings Transcript ↗

April 01, 2026

Legend Biotech (LEGN) Q1 2025 Earnings Transcript

Via The Motley Fool

This Fintech Stock Is Up 21% in a Year as Profits Surge, but One Fund's Nearly $300 Million Sale Cut Its Stake in Half ↗

March 19, 2026

Futu Holdings delivers digital brokerage and wealth management solutions to retail and institutional clients across Asia and global markets.

Via The Motley Fool

These stocks are gapping in today's session ↗

February 23, 2026

Via Chartmill

Legend Biotech Considering Second Listing Outside US: Report ↗

September 05, 2025

Via Stocktwits

How Do Investors Really Feel About Legend Biotech? ↗

September 04, 2025

Via Benzinga

Earnings Outlook For Legend Biotech ↗

August 08, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

February 23, 2026

Via Chartmill

HHLR Advisors Fully Exits Baidu as AI Push Tests Its Advertising-Funded Model ↗

February 20, 2026

Baidu is transitioning from a search-driven advertising company into an AI infrastructure and enterprise cloud provider in China. HHLR’s exit comes as investors weigh whether this transformation will...

Via The Motley Fool

Topics Artificial Intelligence Economy

Arcutis Stock Is Up 100% in a Year but Here’s Why One Fund Still Sold 1 Million Shares ↗

December 23, 2025

Even after cutting back, this remains the fund’s largest bet and the timing lines up with a pivotal stretch for Arcutis’ pipeline.

Via The Motley Fool

Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears ↗

December 23, 2025

When a clinical-stage biotech is sitting on nearly $600 million in cash and lining up an FDA filing, sharp investors stop arguing about the past rally and start debating what comes next.

Via The Motley Fool

Topics Regulatory Compliance

Inside the Fintech Platform Winning Over a New Generation of Investors in Asia ↗

October 31, 2025

Inside the Fintech Platform Winning Over a New Generation of Investors in Asia

Via The Motley Fool

Topics Derivatives Regulatory Compliance

XP’s New Backer Sees Opportunity in Brazil’s Next Financial Chapter ↗

October 30, 2025

XP’s New Backer Sees Opportunity in Brazil’s Next Financial Chapter

Via The Motley Fool

AMD To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Friday ↗

October 17, 2025

Via Benzinga

Johnson & Johnson Stock Falls Premarket: Investors Eye MedTech Growth, Tariff Impact And Drug Pipeline In Q3 Print ↗

October 14, 2025

Investors may also look for updates on J&J’s reported talks to acquire Protagonist Therapeutics to bolster its immunology and oncology pipeline.

Via Stocktwits

Topics Government World Trade

Expert Outlook: Legend Biotech Through The Eyes Of 6 Analysts ↗

October 09, 2025

Via Benzinga

Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings

October 02, 2025

Thousand Oaks, CA – October 2, 2025 – Amgen (NASDAQ: AMGN) has witnessed a robust surge in its share price, climbing approximately 6% in recent trading sessions, culminating on October 2, 2025, to...

Via MarketMinute

Topics Economy Intellectual Property Stocks

The Analyst Verdict: Legend Biotech In The Eyes Of 5 Experts ↗

August 12, 2025

Via Benzinga

Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports

August 11, 2025

Today, August 11, 2025, marks a significant day for investors looking beyond the typical S&P 500 giants, as a diverse array of companies across various sectors unveiled their latest quarterly earnings....

Via MarketMinute

Topics Economy Stocks

Legend Biotech Corp. (NASDAQ:LEGN) Reports Mixed Q2 2025 Earnings with Revenue Beat and EPS Miss Amid Strong CARVYKTI Sales ↗

August 11, 2025

Legend Biotech's Q2 2025 earnings show revenue beat at $255.1M, driven by strong CARVYKTI sales, but EPS missed at -$0.34. Stock rose 1.4% pre-market.

Via Chartmill

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.